# Commission Implementing Regulation (EU) No 201/2014 of 3 March 2014 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance tildipirosin (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance tildipirosin is replaced by the following:
Pharmacologically active Substance
Marker residue
Animal Species
MRL
Target Tissues
Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic classification
‘Tildipirosin
Tildipirosin
Bovine, caprine
400 μg/kg
Muscle
Not for use in animals from which milk is produced for human consumption.
Anti-infectious agents/Antibiotics’
200 μg/kg
Fat
2 000 μg/kg
Liver
3 000 μg/kg
Kidney
Porcine
1 200 μg/kg
Muscle
800 μg/kg
Skin and fat in natural proportions
5 000 μg/kg
Liver
10 000 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/2014/201/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2014-201/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.